Myalept (metreleptin) is the only medication approved for use in people with a rare genetic condition called generalized lipodystrophy (GL). This medication is added onto a dietary plan that your provider recommends you to follow. It's given as an injection under the skin once per day, but is available as brand only, so it can be expensive.
Myalept (metreleptin) is a leptin analog. Leptin is a hormone made in your body that helps regulate (maintain) body weight. It helps use and store fat properly, which affects the level of triglycerides (a type of fat) in your body. Leptin also boosts your body's ability to use blood sugar as energy.
By acting like leptin, Myalept (metreleptin) helps keep the levels of triglycerides and blood sugar low in people with GL who have little to no leptin in their body.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Generalized lipodystrophy (GL) is a rare genetic condition that causes people to have little to no body fat. This results in low leptin levels. Leptin is a hormone released by the fat cells in your body. It regulates your metabolism (how your body uses calories for energy) and helps control your body weight. Complications of GL include high triglyceride (a type of fat) levels, high blood sugar levels (or type 2 diabetes), and fatty liver. Myalept (metreleptin) helps with GL, because it replaces the leptin your body is missing.
No, don't stop taking Myalept (metreleptin) without notifying your provider first. This is especially important if you've had pancreatitis (inflammation of the pancreas) or have severely high triglyceride levels. Stopping the medication suddenly can raise your risk of developing these problems. Let your provider know if you want to stop Myalept (metreleptin) so your dose can be slowly and safely lowered.
No, Myalept (metreleptin) is only for people who are diagnosed with GL. Talk to your provider about available treatment options for diabetes or high cholesterol. They can discuss which option is right for you.
You can give the Myalept (metreleptin) injection under the skin in a body area that has the most fat. These locations include your thigh, back of your upper arm, and stomach. Never inject the medication into your muscle or vein. To lower the risk of bruising and irritation, rotate between different injection sites each time you use the medication so that the same site isn't used repeatedly.
Myalept (metreleptin) hasn't been well studied in human pregnancy, so it's not known whether this medication is safe or works well in pregnant females. Some animal studies that looked at Myalept (metreleptin) use during pregnancy showed that babies weren't harmed from the medication. If you're pregnant or thinking of becoming pregnant, talk with your provider about the risks and benefits of using Myalept (metreleptin) during pregnancy. If you're pregnant and are prescribed Myalept (metreleptin) or become pregnant during treatment, it's recommended that you enroll in a pregnancy exposure registry by calling 1-855-669-2537. This registry can monitor your and your unborn baby's health.
Myalept (metreleptin) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
It's possible for Myalept (metreleptin) to cause your body to make antibodies against leptin or the medication itself and inactivate them. Though not completely clear, this could mean that the medication could start to not work as well, your leptin levels could drop, and certain signs or symptoms of GL could appear. This could include severe infections, diabetes (e.g., high blood sugar, excessive thirst or urination), weight gain, or high triglyceride levels. There are currently ongoing studies that are trying to better understand the clinical impact of this problem.
Although rare, there were reports of lymphoma (a type of immune system cancer) in people taking Myalept (metreleptin) during clinical studies. This only happened in three people using the medication for acquired GL who also had a weakened immune system and bone marrow problems. While there might be a potential risk for lymphoma when treated with Myalept (metreleptin), it's not clear if the medication is linked to this cancer. If you have acquired GL, low blood cell counts, bone marrow problems, or lymph node problems, or if you have any concerns, talk to your provider about this potential risk.
There are potential risks for lymphoma (a type of immune system cancer) and for the development of antibodies that attack leptin in your body. Because of these risks, Myalept (metreleptin) is only available through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the Myalept REMS program. All providers who prescribe Myalept (metreleptin) and pharmacies that dispense the medication must register with the REMS program. Under this program, your provider must discuss the potential risks of Myalept (metreleptin) treatment with you. This program is to make sure the medication is distributed and taken under the safest conditions possible for you.
If you're taking certain other medications that can lower blood sugar (e.g., insulins, sulfonylureas), using Myalept (metreleptin) with these medications can drop your blood sugar even lower to dangerous levels. Tell your provider if you're taking any of these medications, since they might need to adjust your doses to lower your risk. It's important to know how to recognize symptoms of low blood sugar and how to treat it. Always keep emergency glucose tablets or hard candy on you in case your blood sugar drops too low. If you feel faint or experience shaking or sweating, check your blood sugar and treat episodes of low blood sugar right away. If your symptoms don't improve, call 911.
Severe allergic reactions to Myalept (metreleptin) are possible, including life-threatening reactions like facial swelling, shock, and anaphylaxis (e.g., closing of the throat). If you notice difficulty breathing, a choking sensation, dizziness, nausea, or swelling around your eyes, lips, or tongue after using Myalept (metreleptin), get medical attention right away.
To prepare Myalept (metreleptin), the medication can be mixed with sterile water for injection or bacteriostatic water for injection. Bacteriostatic water for injection contains benzyl alcohol, which is a preservative that has caused serious side effects, including death, in children (particularly in newborns and premature babies). If your young child needs to use Myalept (metreleptin), mix the medication with only preservative-free sterile water for injection.
Myalept (metreleptin) is given as an injection under the skin. Your provider will adjust the dose based on how you're responding to the medication.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Myalept (metreleptin) will not be safe for you to take.